Publicacions en què col·labora amb Ruth Maria Rubio Amador (8)

2014

  1. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells

    Stem Cells, Vol. 32, Núm. 5, pp. 1136-1148

2013

  1. Expression of FUS-CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation

    Stem Cells, Vol. 31, Núm. 10, pp. 2061-2072

  2. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development

    Oncogene, Vol. 32, Núm. 41, pp. 4970-4980

2012

  1. Modeling sarcomagenesis using multipotent mesenchymal stem cells

    Cell Research, Vol. 22, Núm. 1, pp. 62-77

2011

  1. Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease

    Stem Cells, Vol. 29, Núm. 2, pp. 251-262

  2. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells

    Stem Cells, Vol. 29, Núm. 2, pp. 179-192

2010

  1. Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo

    Cancer Research, Vol. 70, Núm. 10, pp. 4185-4194

2009

  1. Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells1 2 www.neoplasia.com

    Neoplasia, Vol. 11, Núm. 4, pp. 397-407